These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 20890049)

  • 1. Long-term clinical results and predictors of adverse outcomes after drug-eluting stent implantation for bifurcation lesions in a real-world practice: the COBIS (Coronary Bifurcation Stenting) registry.
    Gwon HC; Choi SH; Song YB; Hahn JY; Jeong MH; Seong IW; Kim HS; Rha SW; Yang JY; Yoon JH; Tahk SJ; Seung KB; Jang Y; Park SJ
    Circ J; 2010 Nov; 74(11):2322-8. PubMed ID: 20890049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Clinical Outcomes of Final Kissing Ballooning in Coronary Bifurcation Lesions Treated With the 1-Stent Technique: Results From the COBIS II Registry (Korean Coronary Bifurcation Stenting Registry).
    Yu CW; Yang JH; Song YB; Hahn JY; Choi SH; Choi JH; Lee HJ; Oh JH; Koo BK; Rha SW; Jeong JO; Jeong MH; Yoon JH; Jang Y; Tahk SJ; Kim HS; Gwon HC
    JACC Cardiovasc Interv; 2015 Aug; 8(10):1297-1307. PubMed ID: 26315732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.
    Claessen BE; Smits PC; Kereiakes DJ; Parise H; Fahy M; Kedhi E; Serruys PW; Lansky AJ; Cristea E; Sudhir K; Sood P; Simonton CA; Stone GW
    JACC Cardiovasc Interv; 2011 Nov; 4(11):1209-15. PubMed ID: 22115661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Final kissing ballooning and long-term clinical outcomes in coronary bifurcation lesions treated with 1-stent technique: results from the COBIS registry.
    Gwon HC; Hahn JY; Koo BK; Song YB; Choi SH; Choi JH; Lee SH; Jeong MH; Kim HS; Seong IW; Yang JY; Rha SW; Jang Y; Yoon JH; Tahk SJ; Seung KB; Park SJ
    Heart; 2012 Feb; 98(3):225-31. PubMed ID: 21933939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug eluting stenting in bifurcation coronary lesions long-term results applying a systematic treatment strategy.
    Assali AR; Vaknin-Assa H; Lev E; Teplitsky I; Dvir D; Brosh D; Bental T; Battler A; Kornowski R
    Catheter Cardiovasc Interv; 2012 Mar; 79(4):615-22. PubMed ID: 22162218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus: 4-year clinical outcomes of DES-DIABETES (drug-eluting stent in patients with DIABETES mellitus) trial.
    Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Kang SJ; Rhee KS; Chae JK; Ko JK; Park JH; Lee JH; Choi SW; Jeong JO; Seong IW; Cho YH; Lee NH; Kim JH; Chun KJ; Kim HS; Park SJ
    JACC Cardiovasc Interv; 2011 Mar; 4(3):310-6. PubMed ID: 21435609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes of sirolimus-eluting stents vs. paclitaxel-eluting stents in unprotected left main coronary artery bifurcation lesions.
    Song PS; Ryu DR; Song YB; Hahn JY; Choi JH; Choi SH; Lee SH; Hong KP; Park JE; Gwon HC
    Clin Cardiol; 2011 Jun; 34(6):378-83. PubMed ID: 21538383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crush stenting with drug-eluting stents: relevance of coronary bifurcation lesion location on angiographic and clinical outcomes.
    Chen SL; Zhang JJ; Ye F; Liu ZZ; Zhu ZS; Lin S; Tian NL; Fang WY; Chen YD; Sun XW; Wei M; Shan SJ; Kan J; Qian J; Yang S; Yuan ZB; Kwan TW; Hu DY
    Clin Cardiol; 2010 Dec; 33(12):E32-9. PubMed ID: 20857513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year clinical follow-up of unprotected left main bifurcation lesion stenting: one-stent versus two-stent techniques versus double-kissing crush technique.
    Chen SL; Zhang Y; Xu B; Ye F; Zhang J; Tian N; Liu Z; Qian X; Ding S; Li F; Zhang A; Liu Y; Lin S
    EuroIntervention; 2012 Nov; 8(7):803-14. PubMed ID: 23171801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative assessment of mammalian target of rapamycin inhibitor-eluting stents in the treatment of coronary artery bifurcation lesions: the CASTOR-Bifurcation registry.
    Sgueglia GA; Burzotta F; Trani C; Todaro D; Talarico GP; Niccoli G; Porto I; Leone AM; Coluccia V; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
    Catheter Cardiovasc Interv; 2011 Mar; 77(4):503-9. PubMed ID: 20602477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-month dual antiplatelet therapy after implantation of zotarolimus-eluting stents: the DATE (Duration of Dual Antiplatelet Therapy AfterImplantation of Endeavor Stent) registry.
    Hahn JY; Song YB; Choi JH; Choi SH; Lee SY; Park HS; Hur SH; Lee S; Han KR; Rha SW; Cho BR; Park JS; Yoon J; Lim DS; Lee SH; Gwon HC;
    Circ J; 2010 Nov; 74(11):2314-21. PubMed ID: 20938098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus- versus paclitaxel-eluting stents for the treatment of coronary bifurcations results: from the COBIS (Coronary Bifurcation Stenting) Registry.
    Song YB; Hahn JY; Choi SH; Choi JH; Lee SH; Jeong MH; Kim HS; Seong IW; Yang JY; Rha SW; Jang Y; Yoon JH; Tahk SJ; Seung KB; Park SJ; Gwon HC
    J Am Coll Cardiol; 2010 Apr; 55(16):1743-50. PubMed ID: 20394879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term clinical results following stenting of the left main stem: insights from RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.
    Onuma Y; Girasis C; Piazza N; Garcia-Garcia HM; Kukreja N; Garg S; Eindhoven J; Cheng JM; Valgimigli M; van Domburg R; Serruys PW;
    JACC Cardiovasc Interv; 2010 Jun; 3(6):584-94. PubMed ID: 20630451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
    Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting.
    Chen SL; Chen JP; Mintz G; Xu B; Kan J; Ye F; Zhang J; Sun X; Xu Y; Jiang Q; Zhang A; Stone GW
    JACC Cardiovasc Interv; 2010 Jun; 3(6):632-41. PubMed ID: 20630456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Clinical Outcomes and Optimal Stent Strategy in Left Main Coronary Bifurcation Stenting.
    Cho S; Kang TS; Kim JS; Hong SJ; Shin DH; Ahn CM; Kim BK; Ko YG; Choi D; Song YB; Hahn JY; Choi SH; Gwon HC; Hong MK; Jang Y
    JACC Cardiovasc Interv; 2018 Jul; 11(13):1247-1258. PubMed ID: 29976361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year clinical outcomes of a polymer-free sirolimus-eluting stent versus a permanent polymer paclitaxel-eluting stent: final results of the intracoronary stenting and angiographic restenosis - test equivalence between two drug-eluting stents (ISAR-TEST) trial.
    King L; Byrne RA; Mehilli J; Schömig A; Kastrati A; Pache J
    Catheter Cardiovasc Interv; 2013 Jan; 81(1):E23-8. PubMed ID: 22431239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries.
    Simsek C; Magro M; Boersma E; Onuma Y; Nauta ST; Gaspersz MP; van der Giessen WJ; van Domburg RT; Serruys PW;
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1051-8. PubMed ID: 20965464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major Predictors of Long-Term Clinical Outcomes After Percutaneous Coronary Intervention for Coronary Bifurcation Lesions With 2-Stent Strategy: Patient-Level Analysis of the Korean Bifurcation Pooled Cohorts.
    Song PS; Song YB; Lee JM; Hahn JY; Choi SH; Choi JH; Lee SH; Park KW; Kim HS; Jang Y; Seung KB; Oh JH; Gwon HC
    JACC Cardiovasc Interv; 2016 Sep; 9(18):1879-86. PubMed ID: 27592016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.